Solid-phase synthesis of carbohydrate and phosphodiester modified 2'-5' oligoadenylate analogs

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 24, 1996, Pages 2993-2998

  Hartsel, Stephanie A ^a   Marshall, William S ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DERIVATIVE; OLIGOADENYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG PURIFICATION; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE;

EID: 0030591857     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00549-5     Document Type: Article

References (30)

1. 1. For reviews: (a) Lengyel, P. Ann. Rev. Biochem. 1982, 51, 251;
2. (b) Pestka, S.; Langer, J. A.; Zoon, K. C.; Samuel, C. E. Ann. Rev. Biochem. 1987, 56, 727.
3. 2. Torrence, P. F.; Xiao, W.; Li, G.; Khamnei, S. Curr. Med. Chem. 1994, 1, 176.
4. 3. (a) Kariko, K.; Sobol, R. W., Jr.; Suhadolnik, L.; Li, S. W.; Reichenbach, N. L.; Suhadolnik, R. J.; Charubala, R.; Pfleiderer, W. Biochemistry 1987, 26, 7127;
5. (b) Kariko, K.; Li, S. W.; Sobol, R. W., Jr.; Suhadolnik, R. J.; Ramamurthy, C.; Pfleiderer, W. Biochemistry 1987, 26, 7136;
6. (c) Suhadolnik, R. J.; Lee, C.; Kariko, K.; Li, S. W. Biochemistry 1987, 26, 7143.
7. 4. (a) Montefiori, D. C.; Sobol, R. W., Jr.; Li, S. W.; Reichenbach, N. L.; Suhadolnik, R. J.; Charubala, R.; Pfleiderer, W.; Modliszewski, A.; Robinson, W. E., Jr.; Mitchell, W. M. Proc. Natl. Acad. Sci. USA 1989, 86, 7191;
8. (b) Charachon, G.; Sobol, R. W., Jr.; Bisbal, C.; Salehzada, T.; Silhol, M.; Charubala, R.; Pfleiderer, W.; Lebleu, B.; Suhadolnik, R. J. Biochemistry 1990, 29, 2550;
9. (c) Muller, W. E. G, Weiler, B. E.; Charubala, R.; Pfleiderer, W.; Leserman, E.; Sobol, R. W., Jr.; Suhadolnik, R. J.; Schroeder, H. C. Biochemistry 1991, 30, 2027.
10. 5. Sobol, R. W.; Charubala, R.; Pfleiderer, W.; Suhadolnik, R. J. Nucleic Acids Res. 1993, 21, 2437 and references therein.
11. 6. Beigelman, L.; Jasenka, M.-A.; Haeberli, P.; Usman, N.; Dong, B.; Silverman, R. H.; Khamnei, S.; Torrence, P. F. Nucleic Acids Res. 1995, 23, 3989.
12. 7. Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543.
13. 8. (a) Caruthers, M. H. Science 1985, 230, 281;
14. (b) Beaucage, S. L.; Iyer, R. P. Tetrahedron 1992, 48, 2223.
15. 9. Norman, D.; Reese, C. Synthesis 1983, 304.
16. 10. Jones, R. A. In Oligonucleotide Synthesis: A Practical Approach; Gait, M.J., Ed.; IRL: Oxford, 1984; pp 25-33.
17. 11. (a) Robins, M. J.; Naik, S. R. Biochim. Biophys. Acta 1971, 246, 341. In our modification, the highly unstable diazomethane was replaced by trimithylsilyl diazomethane in the presence of tin chloride to give a mixture of 2′-and 3′-O-methyl isomers (40% and 60%, respectively);
18. 2O as mobile phase and C-18 silica as solid phase.
19. 12. Dudycz, L.; Wright, G. Nucleosides Nucleotides 1984, 3, 33.
20. 13. Ozols, A.; Azahayev, A.; Dyatkina, N; Kravevsky, A. Synthesis 1980, 557.
21. 14. Heidenreich, O.; Benseler, F.; Fahrenholz, A.; Eckstein, F. J. Biol. Chem. 1994, 269, 2131.
22. 15. Beaton, G.; Dellinger, D.; Marshall, W. S.; Caruthers, M. H. In Oligonucleotides and Analogs: A Practical Approach; Eckstein, F., Ed.; IRL: Oxford, 1991; pp 109-135. In our modification, tris(pyrrolidino)phosphine was prepared as described in Wiesler, W. T.; Marshall, W. S.; Caruthers, M. H. In Methods in Molecular Biology: Protocols for Nucleotides and Analogs; Agrawal, S., Ed.; Humana: Totawa, 1993; Vol 20, pp 191-206. In the second step of phosphorothioamidite preparation, three equivalents of tetrazole were used and reacted for the times noted in the text.
23. 15. Beaton, G.; Dellinger, D.; Marshall, W. S.; Caruthers, M. H. In Oligonucleotides and Analogs: A Practical Approach; Eckstein, F., Ed.; IRL: Oxford, 1991; pp 109-135. In our modification, tris(pyrrolidino)phosphine was prepared as described in Wiesler, W. T.; Marshall, W. S.; Caruthers, M. H. In Methods in Molecular Biology: Protocols for Nucleotides and Analogs; Agrawal, S., Ed.; Humana: Totawa, 1993; Vol 20, pp 191-206. In the second step of phosphorothioamidite preparation, three equivalents of tetrazole were used and reacted for the times noted in the text.
24. 16. Scott, S.; Hardy, P.; Sheppard, R. C.; McLean, M. J. In Innovation and Perspectives in Solid Phase Synthesis: Peptides, Proteins and Nucleic Acids-Biological and Biomedical Applications; Epton, R., Ed.; Mayflower: Birmingham, 1994; pp 115-124.
25. 17. Kamer, P. C. J.; Roelen, H. C. P. F.; van den Elst, H.; van der Marel, G. A.; van Boom, J. H. Tetrahedron Lett. 1989, 30, 6757.
26. 18. Horn, T.; Urdea, M. S. Tetrahedron Lett. 1986, 27, 4705.
27. 19. Dahl, B. H.; Bjergarde, K.; Hendriksen, L.; Dahl, O. Acta Chem. Scand. 1990, 44, 639.
28. 2O with phosphoric acid as external standard; phosphorodithioate, 113 ppm; phosphorothioate, 56 ppm.
29. 4), actual mass 1330.29.
30. 22. Greef, C. H.; Seeberger, P. H.; Caruthers, M. H.; Beaton, G.; Bankaitis-Davis, D. Tetrahedron Lett. 1996, 37, 4451.